Heran Co., Ltd. logo

Heran Co., Ltd. (5283)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
54. 00
+0.3
+0.5587%
NT$
7.41B Market Cap
- P/E Ratio
150% Div Yield
71,159 Volume
- Eps
NT$ 53.7
Previous Close
Add Transaction
Day Range
53.2 54
Year Range
50.9 65.5
Want to track 5283 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

5283 closed today higher at NT$54, an increase of 0.5587% from yesterday's close, completing a monthly increase of 1.8868% or NT$1. Over the past 12 months, 5283 stock lost -10.7438%.
5283 pays dividends to its shareholders, with the most recent payment made on Nov 18, 2025. The next estimated payment will be in In 3 months on Nov 18, 2026 for a total of NT$0.5.
The last earnings report, released on Mar 17, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Heran Co., Ltd. has completed 3 stock splits, with the recent split occurring on Oct 31, 2025.
The company's stock is traded on one exchange.

5283 Chart

People also search for

Nak Sealing Technologies Corp.
NT$ 117.5
-0.8439%
Federal Corporation
NT$ 18.8
+0.8043%
YC Co., Ltd.
NT$ 14.3
-0.6944%
Sampo Corporation
NT$ 23.25
+0.2155%
Power Wind Health Industry Co. Ltd.
NT$ 169.5
-1.1662%

Heran Co., Ltd. (5283) FAQ

What is the stock price today?

The current price is NT$54.00.

On which exchange is it traded?

Heran Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 5283.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 150%.

What is its market cap?

As of today, the market cap is 7.41B.

Has Heran Co., Ltd. ever had a stock split?

Heran Co., Ltd. had 3 splits and the recent split was on Oct 31, 2025.

Heran Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Dong-Yeon Kim CEO
TWSE Exchange
TW0005283006 ISIN
KR Country
666 Employees
27 Mar 2026 Last Dividend
1 Sep 2017 Last Split
- IPO Date

Overview

Ilyang Pharmaceutical Co.,Ltd is a prominent entity in the pharmaceutical industry, primarily operating within South Korea. The inception of the company dates back to 1946, initially known as Il-Yang Pharm. Ind. Co. before it underwent a name change to Ilyang Pharmaceutical Co., Ltd. in May 1991. The company’s headquarters are situated in Yongin, South Korea. Throughout its rich history, Ilyang Pharmaceutical Co.,Ltd has expanded both its product range and market reach, including exports of its products to international markets.

Products and Services

The company’s portfolio is expansive, covering a wide spectrum of medical and health-related products and services:

  • Medicines: Ilyang Pharmaceutical provides a diverse range of medications catering to various health needs, including anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology treatments.
  • Health and Wellness Products: Beyond pharmaceuticals, the company ventures into health drinks, daily food, supplements, health food, cosmetics, and beverages, reflecting its holistic approach to health and wellbeing.
  • Antibiotics and Antifungal Drugs: A critical segment of Ilyang Pharmaceutical’s offerings includes antibiotics and antifungal drugs, combating infections and diseases caused by bacteria and fungi.
  • Anti-inflammatory Analgesic Drugs: These drugs are designed to alleviate pain and reduce inflammation, serving as essential components in pain management and treatment of inflammatory conditions.
  • Insecticides and Vaccines: The company also provides insecticides and vaccines, contributing to public health efforts by controlling insect-borne diseases and preventing viral and bacterial infections.
  • Pharmaceutical Raw Materials Products: Catering to the industry's backend, Ilyang Pharmaceutical produces a broad range of pharmaceutical raw materials, including various forms of aluminum hydroxide, magnesium hydroxide, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, and synthetic aluminum silicate, among others. These raw materials are crucial for the production of numerous pharmaceutical formulations.

Contact Information

Address: 110, Hagal-ro, Yongin, South Korea, 17096
Phone: 82 3 1281 7851